Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PLX
PLX logo

PLX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Protalix Biotherapeutics Inc (PLX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.060
1 Day change
52 Week Range
3.190
Analysis Updated At
2026/06/12
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

PLX is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The pre-market price is near short-term support and momentum is mildly improving, but the broader trend is still bearish and there is no news or catalyst support. The options setup is bullish in positioning, yet the very high implied volatility and lack of a proprietary buy signal make this a wait rather than an immediate buy.

Technical Analysis

Current pre-market price is 2.05, sitting just above the pivot at 2.031 and below resistance at 2.105. MACD histogram is slightly positive and expanding, which suggests near-term momentum improvement. RSI_6 at 60.5 is neutral-to-mildly bullish, not overbought. However, the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, indicating the longer trend is still weak. Overall, the short-term setup is improving, but the longer-term technical trend is not yet constructive enough for a confident long-term entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options positioning is bullish because the open interest put-call ratio of 0.32 is low, showing more call interest than put interest. However, today’s option volume is extremely light, and implied volatility is very elevated at 544.25 with an IV percentile of 96.03, which means options are priced for major movement. That supports speculative sentiment, but not a clean long-term buy signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • ["MACD histogram is positive and expanding, suggesting improving short-term momentum.", "Options positioning is bullish with a low put-call ratio of 0.32.", "Pre-market price is holding above the pivot level at 2.031.", "Stock pattern analysis suggests a modest expected rebound over the next month."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no event-driven catalyst.", "No AI Stock Picker signal today.", "No SwingMax signal recently.", "Moving averages are bearish, indicating the broader trend remains weak.", "Insiders are neutral and hedge funds are neutral, showing no meaningful accumulation signal.", "Implied volatility is extremely high, which usually reflects uncertainty rather than stable upside.", "No recent congress trading data and no notable politician/influencer activity reported."]

Financial Performance

No usable financial snapshot was available because the latest quarter data returned an error. As a result, I cannot confirm revenue or earnings growth trends for the latest quarter season. Based on the provided data alone, there is no financial evidence strong enough to justify a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible evidence of improving Wall Street consensus. Wall Street pros appear neutral at best here: there is no clear bullish catalyst from analysts, no recent positive revisions, and no supporting institutional or insider activity to strengthen the case.

Wall Street analysts forecast PLX stock price to rise
1 Analyst Rating
Wall Street analysts forecast PLX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.060
sliders
Low
12
Averages
12
High
12
Current: 2.060
sliders
Low
12
Averages
12
High
12
Morgan Stanley
Ed Young
Equal Weight
downgrade
AI Analysis
2025-12-16
Reason
Morgan Stanley
Ed Young
Price Target
AI Analysis
2025-12-16
downgrade
Equal Weight
Reason
Morgan Stanley analyst Ed Young lowered the firm's price target on Pluxee to EUR 21 from EUR 23 and keeps an Equal Weight rating on the shares.
JPMorgan
Neutral
downgrade
2025-12-02
Reason
JPMorgan
Price Target
2025-12-02
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Pluxee to EUR 18 from EUR 23 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PLX
Unlock Now

People Also Watch